Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy

Jasmin Stettler(University Hospital of Bern), Thomas Pabst(University Hospital of Bern), Urban Novak(University of Bern), Katja Seipel(University of Bern), Gabriela M. Baerlocher(Terry Fox Research Institute), Behrouz Mansouri Taleghani(University of Bern)

Leukemia & lymphoma/Leukemia and lymphoma

October 13, 2016

10.1080/10428194.2016.1233542

Cited by 23

Related Papers

Mutations in <i>TERT,</i> the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia

|New England Journal of Medicine|2005|717

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

|Leukemia|2012|417

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

|Leukemia|2017|339

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

|Journal of Clinical Oncology|2013|299

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

|Blood|2011|289